rs397515426
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_002768.5(CHMP1A):c.88C>T(p.Gln30*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,613,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000096 ( 0 hom. )
Consequence
CHMP1A
NM_002768.5 stop_gained
NM_002768.5 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 9.58
Genes affected
CHMP1A (HGNC:8740): (charged multivesicular body protein 1A) This gene encodes a member of the CHMP/Chmp family of proteins which are involved in multivesicular body sorting of proteins to the interiors of lysosomes. The initial prediction of the protein sequence encoded by this gene suggested that the encoded protein was a metallopeptidase. The nomenclature has been updated recently to reflect the correct biological function of this encoded protein. Several transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.851 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-89651586-G-A is Pathogenic according to our data. Variant chr16-89651586-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 39837.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP1A | NM_002768.5 | c.88C>T | p.Gln30* | stop_gained | 3/7 | ENST00000397901.8 | NP_002759.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP1A | ENST00000397901.8 | c.88C>T | p.Gln30* | stop_gained | 3/7 | 1 | NM_002768.5 | ENSP00000380998.3 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152196Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
19
AN:
152196
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248480Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135076
GnomAD3 exomes
AF:
AC:
1
AN:
248480
Hom.:
AF XY:
AC XY:
0
AN XY:
135076
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461418Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726986
GnomAD4 exome
AF:
AC:
14
AN:
1461418
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 152196Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74336
GnomAD4 genome
AF:
AC:
19
AN:
152196
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Pontocerebellar hypoplasia type 8 Pathogenic:3Uncertain:1
Uncertain significance, flagged submission | clinical testing | Revvity Omics, Revvity | Jun 16, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 04, 2014 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2012 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 18, 2020 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change creates a premature translational stop signal (p.Gln30*) in the CHMP1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHMP1A are known to be pathogenic (PMID: 23023333). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with pontocerebellar hypoplasia and microcephaly (PMID: 23023333). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 39837). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 24, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23023333, 27535533) - |
CHMP1A-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 27, 2024 | The CHMP1A c.88C>T variant is predicted to result in premature protein termination (p.Gln30*). This variant, in the homozygous state, has been reported in three individuals from two families with pontocerebellar hypoplasia & microcephaly (Mochida et al 2012. PubMed ID: 23023333). This variant is reported in 0.0028% of alleles in individuals of Latino descent in gnomAD. Nonsense variants in CHMP1A are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at